Dynavax Technologies Corporation (DVAX)
Dynavax Statistics
Share Statistics
Dynavax has 122.41M shares outstanding. The number of shares has increased by -5.21% in one year.
| Shares Outstanding | 122.41M |
| Shares Change (YoY) | -5.21% |
| Shares Change (QoQ) | -5.62% |
| Owned by Institutions (%) | 99.55% |
| Shares Floating | 116.71M |
| Failed to Deliver (FTD) Shares | 36 |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
The latest short interest is 17.86M, so 14.59% of the outstanding shares have been sold short.
| Short Interest | 17.86M |
| Short % of Shares Out | 14.59% |
| Short % of Float | 21.52% |
| Short Ratio (days to cover) | 5.67 |
Valuation Ratios
The PE ratio is 60.81 and the forward PE ratio is 20.12. Dynavax's PEG ratio is -0.12.
| PE Ratio | 60.81 |
| Forward PE | 20.12 |
| PS Ratio | 5.99 |
| Forward PS | 2.2 |
| PB Ratio | 2.78 |
| P/FCF Ratio | 27.6 |
| PEG Ratio | -0.12 |
Enterprise Valuation
Dynavax has an Enterprise Value (EV) of 1.82B.
| EV / Sales | 6.55 |
| EV / EBITDA | 39.72 |
| EV / EBIT | 27.29 |
| EV / FCF | 30.17 |
Financial Position
The company has a current ratio of 10.8, with a Debt / Equity ratio of 0.42.
| Current Ratio | 10.8 |
| Quick Ratio | 9.91 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | 5.48 |
| Debt / FCF | 4.16 |
| Interest Coverage | -0.61 |
Financial Efficiency
Return on Equity is 4.58% and Return on Invested Capital is -0.4%.
| Return on Equity | 4.58% |
| Return on Assets | 2.77% |
| Return on Invested Capital | -0.4% |
| Revenue Per Employee | $684.56K |
| Profits Per Employee | $67.43K |
| Employee Count | 405 |
| Asset Turnover | 0.28 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 3.55M |
| Effective Tax Rate | 11.49% |
Stock Price Statistics
The stock price has increased by 1.58% in the last 52 weeks. The beta is 1.26, so Dynavax's price volatility has been higher than the market average.
| Beta | 1.26 |
| 52-Week Price Change | 1.58% |
| 50-Day Moving Average | 12.81 |
| 200-Day Moving Average | 12.08 |
| Relative Strength Index (RSI) | 46.46 |
| Average Volume (20 Days) | 2.48M |
Income Statement
In the last 12 months, Dynavax had revenue of 277.25M and earned 27.31M in profits. Earnings per share was 0.21.
| Revenue | 277.25M |
| Gross Profit | 277.25M |
| Operating Income | -4.12M |
| Net Income | 27.31M |
| EBITDA | 45.7M |
| EBIT | 37.65M |
| Earnings Per Share (EPS) | 0.21 |
Balance Sheet
The company has 95.88M in cash and 250.24M in debt, giving a net cash position of -154.36M.
| Cash & Cash Equivalents | 95.88M |
| Total Debt | 250.24M |
| Net Cash | -154.36M |
| Retained Earnings | -903.27M |
| Total Assets | 986.26M |
| Working Capital | 770.31M |
Cash Flow
In the last 12 months, operating cash flow was 66.51M and capital expenditures -6.35M, giving a free cash flow of 60.16M.
| Operating Cash Flow | 66.51M |
| Capital Expenditures | -6.35M |
| Free Cash Flow | 60.16M |
| FCF Per Share | 0.46 |
Margins
Gross margin is 100%, with operating and profit margins of -1.49% and 9.85%.
| Gross Margin | 100% |
| Operating Margin | -1.49% |
| Pretax Margin | 11.13% |
| Profit Margin | 9.85% |
| EBITDA Margin | 16.48% |
| EBIT Margin | -1.49% |
| FCF Margin | 21.7% |
Dividends & Yields
DVAX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 1.64% |
| FCF Yield | 3.62% |
Analyst Forecast
The average price target for DVAX is $31, which is 168.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $31 |
| Price Target Difference | 168.4% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
Stock Splits
The last stock split was on Nov 10, 2014. It was a backward split with a ratio of 1:10.
| Last Split Date | Nov 10, 2014 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | 2.15 |
| Piotroski F-Score | 6 |